DOCSLIB.ORG

Role of Androgen Receptor Nuclear

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of Androgen Receptor Nuclear The effect of the polyglutamine expansion of the Androgen Receptor on the ubiquitin proteasome system for protein degradation Thomas Carr Scanlon Department of Human Genetics McGill University, Montreal, Quebec August, 2007 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Doctor of Philosophy © Thomas Scanlon, 2007 i Library and Archives Bibliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de I'edition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 Ottawa ON K1A0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-53327-7 Our file Notre reference ISBN: 978-0-494-53327-7 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Bibliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par Nnternet, prefer, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non­ support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in this et des droits moraux qui protege cette these. Ni thesis. Neither the thesis nor la these ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent etre imprimes ou autrement printed or otherwise reproduced reproduits sans son autorisation. without the author's permission. In compliance with the Canadian Conformement a la loi canadienne sur la Privacy Act some supporting forms protection de la vie privee, quelques may have been removed from this formulaires secondaires ont ete enleves de thesis. cette these. While these forms may be included Bien que ces formulaires aient inclus dans in the document page count, their la pagination, il n'y aura aucun contenu removal does not represent any loss manquant. of content from the thesis. 1*1 Canada ABSTRACT The Androgen Receptor (AR; Xql 1.2-ql2) is a well-characterized X-linked gene. The AR protein functions primarily as a steroid-activated transcription factor. A structural feature of the AR transactivational domain (TAD) called the polyglutamine tract will be the primary focus of this thesis. The polyglutamine tract is an uninterrupted stretch of glutamine residues, polymorphic in length, that contributes to the transactivational potential of the receptor, and has also been demonstrated to be the causative agent in Spinal and Bulbar Muscular Atrophy (SBMA). SBMA is a late-onset neurological disease caused by an expansion of the polyglutamine tract in the AR. Immunohistopathological investigations of affected tissue in SBMA patients reveal strong anti-AR staining in discrete, electrodense regions, termed "inclusion bodies" or "protein aggregates". This finding has been corroborated by various transfection studies comparing wild type and polyglutamine tract-expanded AR, leading to a large variety of hypotheses regarding the formation and potential toxicity of .these structures. The consistent observation of accumulated, insoluble polyglutamine - expanded protein suggests a malfunction of the normal mechanisms of protein clearance. The primary goal of this thesis is to explore the effect of the polyglutamine expansion mutation in the AR on the ubiquitin proteasome system of protein degradation (UPS). To this end, several strategies have been implemented. A classic proteasome reporter cell line was used to create a cell culture model of SBMA to show evidence for involvement of the UPS in SBMA. To investigate the putative nuclear dependence of polyglutamine-mediated toxicity, transfection studies using a mutant AR with defective n nuclear localization signal were also performed in this cell line. In an attempt to unequivocally demonstrate polyglutamine-expanded protein degradation by the proteasome, efforts were made to create an entirely in vitro method to test AR degradation by the UPS. Human proteasomes were successfully purified by a novel affinity chromatography method towards this end. Finally, the AR TAD with various polyglutamine tract lengths was bacterially- expressed and highly purified for structural analysis of the polyglutamine tract in a native protein. Dynamic light scattering experiments demonstrated expanded polyQ tracts exhibit biochemical aggregative properties. Circular dichroism spectra were collected for each polyQ tract variant. Results indicated any length polyQ tract is an strong structure- breaking sequence. Furthermore, the expansion mutant exhibited pronounced P-sheet strucutre absent from all other variants. In sum, structural investigations suggest a molten globule structure for the wild type AR-TAD. in RESUME Le recepteur androgene (AR), un gene situe sur le chromosome X en position Xqll.2-ql2 est, a prime abord, un facteur transcriptionnel active via les hormones steroidiennes. Le sujet de cette these se concentre suf un domaine structural du recepteur androgene, lequel s'avere necessaire pour l'activite transcriptionnelle du recepteur. Ce domaine nomme «polyglutamine tract» consiste en une sequence repetitive et ininterrompue de glutamine dont le nombre est polymorphe. Le nombre de repetition affecte directement le potentiel transactivationnel du recepteur et s'avere etre l'element causal de l'atrophie spinobulbaire (SBMA; SpinoBulbar Muscular Atrophy). L'atrophie spinobulbaire est une maladie neurologique se developpant tardivement chez l'adulte. Celle-ci est causee par une expansion du nombre de repetition de glutamine formant le « polyglutamine tract » du recepteur androgene. L'investigation par immunohistopathologie de tissus provenant de patients atteints de SBMA revele une concentration dense du recepteur androgene sous forme d'agregats proteiques nomme corps d'inclusion. Cette decouverte sur le potentiel toxique de ces structures a ete corroboree par plusieurs etudes de subexpression du gene AR normal (WT; Wild Type) ainsi que la version ayant subie une expansion du nombre de glutamine. L'observation constante des agregats insolubles de la proteine AR portant l'expansion de glutamine suggere un probleme au niveau de sa gestion par les mecanismes de degradation proteiques normaux. IV Le but premier de cette these est d'explorer les effets causes sur la degradation par le systeme ubiquitine/proteasome (UPS) du recepteur androgene a la suite d'une expansion du nombre de repetition de glutamine dans le gene. Pour ce faire, plusieurs strategies ont dues etre utilisees a l'aide d'une lignee cellulaire servant de modele pour l'atrophie spinobulbaire (SBMA). Pour montrer l'effet de la localisation nucleaire de la proteine du recepteur androgene portant une expansion de glutamine sur la toxicite cellulaire, des etudes de transfection de la proteine mutante portant aussi un signal de localisation nucleaire deficient ont ete utilisees. Afin de demontrer l'effet de l'expansion de la repetition de glutamine, des proteasomes humains ont ete purifies par chromatographic d'affinite afin de tester l'efficacite de la degradation de constructions du recepteur androgene arborant differentes longueurs de repetition de glutamine. v ACKNOWLEDGEMENTS In the spirit of full disclosure, it is acknowledged that the author was the beneficiary of excellent guidance and spirited discussion of this thesis and all aspects of science (ranging from the appropritately relevant to the wildly speculative) with my supervisor, Dr. Mark Trifiro. In addition, considerable time and effort in the design of experiments, interpretation of results and suggestion of controls was provided by several members of the Trifiro laboratory: Dr. Lenore K. Beitel, Carlos Alvarado, Rose Lumbroso, and Dr. Bruce Gottlieb. It should be expressly stated that tandem mass spectrometry of purified proteasome fractions was performed on a fee-for-service basis by Dr. Marcos DiFalco at the McGill University and Genome Quebec Innovation Centre. Database mining of the resultant LC-MS/MS data was performed by the author with the assistance of Dr. Beniot Houle and Yannic Richard of the same institution. Finally, the LC-MS/MS data from proteasome purifications was searched against a randomized version of the NCBI database by Dr. Rob Kearney, also of the McGill University and Genome Quebec Innovation Centre. Materials were gathered from various sources for completion of the research described in this thesis. Dr. Ron Kopito provided the HEK-293 GFP" cell line. In addition, several expression vectors for transfection experiments had already been constructed by various members of the Trifiro laboratory including EBFP-AR -Q20 and - Q50; ARANLS -Q20 and -Q50 plasmids, and the bacterial N-terminal TAD expression vectors. In addition, the GST-UBL was provided by Dr. Juli Feigon, University of California at Los Angeles, and the pMT123 expression vector was a gift from Dr. Simon Wing, McGill University. All other DNA vectors were constructed by the author. Finally, it would have been impossible to complete this work without the unconditional love and suppport from my parents, Timothy and Barbara Scanlon. Additionally, I would like to express gratitude for which there are no words to
Load more

Recommended publications
  • Supplementary Figures 1-14 and Supplementary References
    SUPPORTING INFORMATION Spatial Cross-Talk Between Oxidative Stress and DNA Replication in Human Fibroblasts Marko Radulovic,1,2 Noor O Baqader,1 Kai Stoeber,3† and Jasminka Godovac-Zimmermann1* 1Division of Medicine, University College London, Center for Nephrology, Royal Free Campus, Rowland Hill Street, London, NW3 2PF, UK. 2Insitute of Oncology and Radiology, Pasterova 14, 11000 Belgrade, Serbia 3Research Department of Pathology and UCL Cancer Institute, Rockefeller Building, University College London, University Street, London WC1E 6JJ, UK †Present Address: Shionogi Europe, 33 Kingsway, Holborn, London WC2B 6UF, UK TABLE OF CONTENTS 1. Supplementary Figures 1-14 and Supplementary References. Figure S-1. Network and joint spatial razor plot for 18 enzymes of glycolysis and the pentose phosphate shunt. Figure S-2. Correlation of SILAC ratios between OXS and OAC for proteins assigned to the SAME class. Figure S-3. Overlap matrix (r = 1) for groups of CORUM complexes containing 19 proteins of the 49-set. Figure S-4. Joint spatial razor plots for the Nop56p complex and FIB-associated complex involved in ribosome biogenesis. Figure S-5. Analysis of the response of emerin nuclear envelope complexes to OXS and OAC. Figure S-6. Joint spatial razor plots for the CCT protein folding complex, ATP synthase and V-Type ATPase. Figure S-7. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated by GO to nucleocytoplasmic transport (GO:0006913). Figure S-8. Joint spatial razor plots showing changes in subcellular abundance and compartmental distribution for proteins annotated to endocytosis (GO:0006897). Figure S-9. Joint spatial razor plots for 401-set proteins annotated by GO to small GTPase mediated signal transduction (GO:0007264) and/or GTPase activity (GO:0003924).
    [Show full text]
  • Supplementary Table S1. Correlation Between the Mutant P53-Interacting Partners and PTTG3P, PTTG1 and PTTG2, Based on Data from Starbase V3.0 Database
    Supplementary Table S1. Correlation between the mutant p53-interacting partners and PTTG3P, PTTG1 and PTTG2, based on data from StarBase v3.0 database. PTTG3P PTTG1 PTTG2 Gene ID Coefficient-R p-value Coefficient-R p-value Coefficient-R p-value NF-YA ENSG00000001167 −0.077 8.59e-2 −0.210 2.09e-6 −0.122 6.23e-3 NF-YB ENSG00000120837 0.176 7.12e-5 0.227 2.82e-7 0.094 3.59e-2 NF-YC ENSG00000066136 0.124 5.45e-3 0.124 5.40e-3 0.051 2.51e-1 Sp1 ENSG00000185591 −0.014 7.50e-1 −0.201 5.82e-6 −0.072 1.07e-1 Ets-1 ENSG00000134954 −0.096 3.14e-2 −0.257 4.83e-9 0.034 4.46e-1 VDR ENSG00000111424 −0.091 4.10e-2 −0.216 1.03e-6 0.014 7.48e-1 SREBP-2 ENSG00000198911 −0.064 1.53e-1 −0.147 9.27e-4 −0.073 1.01e-1 TopBP1 ENSG00000163781 0.067 1.36e-1 0.051 2.57e-1 −0.020 6.57e-1 Pin1 ENSG00000127445 0.250 1.40e-8 0.571 9.56e-45 0.187 2.52e-5 MRE11 ENSG00000020922 0.063 1.56e-1 −0.007 8.81e-1 −0.024 5.93e-1 PML ENSG00000140464 0.072 1.05e-1 0.217 9.36e-7 0.166 1.85e-4 p63 ENSG00000073282 −0.120 7.04e-3 −0.283 1.08e-10 −0.198 7.71e-6 p73 ENSG00000078900 0.104 2.03e-2 0.258 4.67e-9 0.097 3.02e-2 Supplementary Table S2.
    [Show full text]
  • Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes
    International Journal of Environmental Research and Public Health Article Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes Yueh-Han Hsu 1,2, Peng-Hui Wang 1,2,3,4,5 and Chia-Ming Chang 1,2,* 1 Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei 112, Taiwan; [email protected] (Y.-H.H.); [email protected] (P.-H.W.) 2 School of Medicine, National Yang-Ming University, Taipei 112, Taiwan 3 Institute of Clinical Medicine, National Yang-Ming University, Taipei 112, Taiwan 4 Department of Medical Research, China Medical University Hospital, Taichung 440, Taiwan 5 Female Cancer Foundation, Taipei 104, Taiwan * Correspondence: [email protected]; Tel.: +886-2-2875-7826; Fax: +886-2-5570-2788 Received: 27 April 2020; Accepted: 31 May 2020; Published: 2 June 2020 Abstract: Clear cell carcinoma of the ovary (ovarian clear cell carcinoma (OCCC)) is one epithelial ovarian carcinoma that is known to have a poor prognosis and a tendency for being refractory to treatment due to unclear pathogenesis. Published investigations of OCCC have mainly focused only on individual genes and lack of systematic integrated research to analyze the pathogenesis of OCCC in a genome-wide perspective. Thus, we conducted an integrated analysis using transcriptome datasets from a public domain database to determine genes that may be implicated in the pathogenesis involved in OCCC carcinogenesis. We used the data obtained from the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) DataSets. We found six interactive functional gene clusters in the pathogenesis network of OCCC, including ribosomal protein, eukaryotic translation initiation factors, lactate, prostaglandin, proteasome, and insulin-like growth factor.
    [Show full text]
  • A Knowledge-Guided Mechanistic Model of Synthetic Lethality in The
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.22.449530; this version posted June 23, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A Knowledge-guided Mechanistic Model of Synthetic Lethality in the HCT116 Vorinostat-resistant Colon Cancer Xenograft Model Cell-line Paul Aiyetan June 22, 2021 Abstract With an overall lifetime risk of about 4.3% and 4.0%, in men and women respectively, colorectal cancer remains the third leading cause of cancer-related deaths in the United States. In persons aged 55 and below, its rate increased at 1% per year in the years 2008 to 2017 despite the steady decline associated with improved screening, early diagnosis and treatment in the general population. Besides standardized therapeutic regimen, many trials continue to evaluate the potential benefits of vorinostat, mostly in combination with other anti-neoplastic agents for its treatment. Vorinostat, an FDA approved anti-cancer drug known as suberoylanilide hydroxamic acid (SAHA), an histone deacylase (HDAC) inhibitor, through many mechanisms, causes cancer cell arrest and death. However, like many other anti-neoplastic agents, resistance and or failures have been observed. In the HCT116 colon cancer cell line xenograft model, exploiting potential lethal molecular interactions by additional gene knockouts restored vorinotat sensitivity. This phenomenon, known as synthetic lethality, offers a promise to selectively target cancer cells. Although without clearly delineated understanding of underlying molecular processes, it has been demonstrated as an effective cancer-killing mechanism.
    [Show full text]
  • Genome-Wide Transcript and Protein Analysis Reveals Distinct Features of Aging in the Mouse Heart
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.28.272260; this version posted April 21, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Genome-wide transcript and protein analysis reveals distinct features of aging in the mouse heart Isabela Gerdes Gyuricza1, Joel M. Chick2, Gregory R. Keele1, Andrew G. Deighan1, Steven C. Munger1, Ron Korstanje1, Steven P. Gygi3, Gary A. Churchill1 1The Jackson Laboratory, Bar Harbor, Maine 04609 USA; 2Vividion Therapeutics, San Diego, California 92121, USA; 3Harvard Medical School, Boston, Massachusetts 02115, USA Corresponding author: [email protected] Key words for online indexing: Heart Aging Transcriptomics Proteomics eQTL pQTL Stoichiometry ABSTRACT Investigation of the molecular mechanisms of aging in the human heart is challenging due to confounding factors, such as diet and medications, as well limited access to tissues. The laboratory mouse provides an ideal model to study aging in healthy individuals in a controlled environment. However, previous mouse studies have examined only a narrow range of the genetic variation that shapes individual differences during aging. Here, we analyzed transcriptome and proteome data from hearts of genetically diverse mice at ages 6, 12 and 18 months to characterize molecular changes that occur in the aging heart. Transcripts and proteins reveal distinct biological processes that are altered through the course of natural aging. Transcriptome analysis reveals a scenario of cardiac hypertrophy, fibrosis, and reemergence of fetal gene expression patterns.
    [Show full text]
  • In Silico Analysis of IDH3A Gene Revealed Novel Mutations Associated with Retinitis Pigmentosa
    bioRxiv preprint doi: https://doi.org/10.1101/554196; this version posted February 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. In silico analysis of IDH3A gene revealed Novel mutations associated with Retinitis Pigmentosa Thwayba A. Mahmoud1*, Abdelrahman H. Abdelmoneim1, Naseem S. Murshed1, Zainab O. Mohammed2, Dina T. Ahmed1, Fatima A. Altyeb1, Nuha A. Mahmoud3, Mayada A. Mohammed1, Fatima A. Arayah1, Wafaa I. Mohammed1, Omnia S. Abayazed1, Amna S. Akasha1, Mujahed I. Mustafa1,4, Mohamed A. Hassan1 1- Department of Biotechnology, Africa city of Technology, Sudan 2- Hematology Department, Ribat University Hospital, Sudan 3- Biochemistry Department, faculty of Medicine, National University, Sudan 4- Department of Biochemistry, University of Bahri, Sudan *Corresponding Author: Thwayba A. Mahmoud, Email: [email protected] Abstract: Background: Retinitis Pigmentosa (RP) refers to a group of inherited disorders characterized by the death of photoreceptor cells leading to blindness. The aim of this study is to identify the pathogenic SNPs in the IDH3A gene and their effect on the structure and function of the protein. Method: we used different bioinformatics tools to predict the effect of each SNP on the structure and function of the protein. Result: 20 deleterious SNPs out of 178 were found to have a damaging effect on the protein structure and function. Conclusion: this is the first in silico analysis of IDH3A gene and 20 novel mutations were found using different bioinformatics tools, and they could be used as diagnostic markers for Retinitis Pigmentosa.
    [Show full text]
  • PSMD13 Antibody (C-Term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap2915b
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 PSMD13 Antibody (C-term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP2915b Specification PSMD13 Antibody (C-term) - Product Information Application WB, IHC-P, FC,E Primary Accession Q9UNM6 Other Accession B0BN93, Q9WVJ2, P84169 Reactivity Human Predicted Chicken, Mouse, Rat Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Calculated MW 42945 Antigen Region 269-298 PSMD13 Antibody (C-term) - Additional Information Anti-PSMD13 Antibody (C-term) at 1:1000 Gene ID 5719 dilution + Jurkat whole cell lysate Lysates/proteins at 20 µg per lane. Other Names Secondary Goat Anti-Rabbit IgG, (H+L), 26S proteasome non-ATPase regulatory Peroxidase conjugated at 1/10000 dilution. subunit 13, 26S proteasome regulatory Predicted band size : 43 kDa subunit RPN9, 26S proteasome regulatory subunit S11, 26S proteasome regulatory Blocking/Dilution buffer: 5% NFDM/TBST. subunit p405, PSMD13 Target/Specificity This PSMD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 269-298 amino acids from the C-terminal region of human PSMD13. Dilution WB~~1:1000 IHC-P~~1:50~100 FC~~1:10~50 Format Purified polyclonal antibody supplied in PBS Western blot analysis of PSMD13 Antibody with 0.09% (W/V) sodium azide. This (C-term) (Cat. #AP2915b) in Y79 cell line antibody is purified through a protein A lysates (35ug/lane). PSMD13 (arrow) was column, followed by peptide affinity detected using the purified Pab. purification. Storage Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Maintain refrigerated at 2-8°C for up to 2 weeks.
    [Show full text]
  • Functional Analysis of Rice Bidirectional Promoters
    Michigan Technological University Digital Commons @ Michigan Tech Dissertations, Master's Theses and Master's Dissertations, Master's Theses and Master's Reports - Open Reports 2012 Functional analysis of rice bidirectional promoters Surendar R. Dhadi Michigan Technological University Follow this and additional works at: https://digitalcommons.mtu.edu/etds Part of the Biology Commons Copyright 2012 Surendar R. Dhadi Recommended Citation Dhadi, Surendar R., "Functional analysis of rice bidirectional promoters", Dissertation, Michigan Technological University, 2012. https://doi.org/10.37099/mtu.dc.etds/191 Follow this and additional works at: https://digitalcommons.mtu.edu/etds Part of the Biology Commons FUNCTIONAL ANALYSIS OF RICE BIDIRECTIONAL PROMOTERS By Surendar R Dhadi A DISSERTATION Submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY (Biological Sciences) MICHIGAN TECHNOLOGICAL UNIVERSITY 2012 Copyright © Surendar R Dhadi 2012 This dissertation, “Functional Analysis of Rice Bidirectional Promoters”, is hereby approved in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY IN BIOLOGICAL SCIENCES. Department of Biological Sciences Signatures: Dissertation Advisor ________________________________________ Ramakrishna Wusirika Department Chair ________________________________________ K. Michael Gibson Date ________________________________________ TABLE OF CONTENTS List of Figures..........................................................................................................................
    [Show full text]
  • Gad.1600107.Full.Pdf
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Genomic profiling and expression studies reveal both positive and negative activities for the Drosophila Myb–MuvB/dREAM complex in proliferating cells Daphne Georlette,1 Soyeon Ahn,2 David M. MacAlpine,3,5 Evelyn Cheung,4 Peter W. Lewis,1 Eileen L. Beall,1 Stephen P. Bell,3 Terry Speed,2 J. Robert Manak,4 and Michael R. Botchan1,6 1Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 94720, USA; 2Department of Statistics, University of California Berkeley, Berkeley, California 94720, USA; 3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 4Affymetrix, Inc., Affy Laboratories-Transcriptome, Santa Clara, California 95051, USA Myb–MuvB (MMB)/dREAM is a nine-subunit complex first described in Drosophila as a repressor of transcription, dependent on E2F2 and the RBFs. Myb, an integral member of MMB, curiously plays no role in the silencing of the test genes previously analyzed. Moreover, Myb plays an activating role in DNA replication in Drosophila egg chamber follicle cells. The essential functions for Myb are executed as part of MMB. This duality of function lead to the hypothesis that MMB, which contains both known activator and repressor proteins, might function as part of a switching mechanism that is dependent on DNA sites and developmental context. Here, we used proliferating Drosophila Kc tissue culture cells to explore both the network of genes regulated by MMB (employing RNA interference and microarray expression analysis) and the genomic locations of MMB following chromatin immunoprecipitation (ChIP) and tiling array analysis.
    [Show full text]
  • Systems Biology Analysis of Osteogenic Differentiation Behavior
    www.nature.com/scientificreports OPEN Systems biology analysis of osteogenic diferentiation behavior by canine mesenchymal stem cells derived from bone marrow and dental pulp Sirirat Nantavisai1,2,3, Trairak Pisitkun4, Thanaphum Osathanon5,6, Prasit Pavasant5,6, Chanin Kalpravidh7, Sirakarnt Dhitavat8, Jiradej Makjaroen4 & Chenphop Sawangmake2,3,9* Utilization of canine mesenchymal stem cells (cMSCs) for regenerating incorrigible bone diseases has been introduced. However, cMSCs harvested from diferent sources showed distinct osteogenicity. To clarify this, comparative proteomics-based systems biology analysis was used to analyze osteogenic diferentiation behavior by cMSCs harvested from bone marrow and dental pulp. The results illustrated that canine dental pulp stem cells (cDPSCs) contained superior osteogenicity comparing with canine bone marrow-derived MSCs (cBM-MSCs) regarding alkaline phosphatase activity, matrix mineralization, and osteogenic marker expression. Global analyses by proteomics platform showed distinct protein clustering and expression pattern upon an in vitro osteogenic induction between them. Database annotation using Reactome and DAVID revealed contrast and unique expression profle of osteogenesis-related proteins, particularly on signaling pathways, cellular components and processes, and cellular metabolisms. Functional assay and hierarchical clustering for tracking protein dynamic change confrmed that cBM-MSCs required the presences of Wnt, transforming growth factor (TGF)-beta, and bone-morphogenetic protein (BMP) signaling, while cDPSCs mainly relied on BMP signaling presentation during osteogenic diferentiation in vitro. Therefore, these fndings illustrated the comprehensive data regarding an in vitro osteogenic diferentiation behavior by cBM-MSCs and cDPSCs which is crucial for further mechanism study and the establishment of cMSC-based bone tissue engineering (BTE) for veterinary practice. Regenerative therapy for reconstructing craniofacial and bone defects is a challenge procedure especially for vet- erinary practice1.
    [Show full text]
  • Supplementary Table 4: the Association of the 26S Proteasome
    Supplementary Material (ESI) for Molecular BioSystems This journal is (c) The Royal Society of Chemistry, 2009 Supplementary Table 4: The association of the 26S proteasome and tumor progression/metastasis Note: the associateion between cancer and the 26S proteasome genes has been manually checked in PubMed a) GSE2514 (Lung cancer, 20 tumor and 19 normal samples; 25 out of 43 26S proteasome genes were mapped on the microarray platform. FWER p-value: 0.02) Entrez GeneID Gene Symbol RANK METRIC SCORE* Genes have been reported in cancer 10213 PSMD14 0.288528293 5710 PSMD4 0.165639699 Kim et al., Mol Cancer Res., 6:426, 2008 5713 PSMD7 0.147187442 5721 PSME2 0.130215749 5717 PSMD11 0.128598183 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 5704 PSMC4 0.123157509 5706 PSMC6 0.115970835 5716 PSMD10 0.112173758 Mayer et al., Biochem Society Transaction, 34:746, 2006 5700 PSMC1 0.0898761 Kim et al., Mol Cancer Res., 6:426, 2008 5701 PSMC2 0.081513479 Cui et al., Proteomics, 6:498, 2005 5709 PSMD3 0.071682706 5719 PSMD13 0.071118504 7415 VCP 0.060464829 9861 PSMD6 0.055711303 Ren et al., Oncogene, 19:1419, 2000 5720 PSME1 0.052469168 5714 PSMD8 0.047414459 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 5702 PSMC3 0.046327863 Pollice et al., JBC, 279:6345, 2003 6184 RPN1 0.043426223 55559 UCHL5IP 0.041885283 5705 PSMC5 0.041615516 5715 PSMD9 0.033147983 5711 PSMD5 0.030562362 Deng et al., Breast Cancer Research and Treatment, 104:1067, 2007 10197 PSME3 0.015149679 Roessler et al., Molecular & Cellular Proteomics 5:2092, 2006 5718 PSMD12 -0.00983229 Cui et al., Proteomics, 6:498, 2005 9491 PSMF1 -0.069156095 *Positive rank metric score represent that a gene is highly expressed in tumors.
    [Show full text]
  • The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma
    Hindawi BioMed Research International Volume 2021, Article ID 9922185, 9 pages https://doi.org/10.1155/2021/9922185 Research Article The Silence of PSMC6 Inhibits Cell Growth and Metastasis in Lung Adenocarcinoma Jian-Yu Zhang, Ke-Zhi Shi, Xiang-Yu Liao, Shi-Jun Li, Dan Bao, Ying Qian, and Dao-Jun Li The First College of Clinical Medical Science, Three Gorges University & Yichang Central People’s Hospital, Yichang, China Correspondence should be addressed to Dao-Jun Li; [email protected] Received 8 March 2021; Revised 24 April 2021; Accepted 28 May 2021; Published 19 June 2021 Academic Editor: Tao Huang Copyright © 2021 Jian-Yu Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The proteasome has been validated as an anticancer drug target, while the role of a subunit of proteasome, PSMC6, in lung adenocarcinoma (LUAD) has not been fully unveiled. In this study, we observed that both the RNA and protein of PSMC6 were highly upregulated in LUAD compared with the adjacent normal tissues. Moreover, a high PSMC6 expression was associated with poor prognosis. In accordance with this finding, PSMC6 was associated with poor tumor differentiation. Furthermore, the silence of PSMC6 by small interference RNAs (siRNAs) could significantly inhibit cell growth, migration, and invasion in lung cancer cell lines, suggesting that PSMC6 might serve as a promising therapeutic target in LUAD. To further explore the molecular mechanism of PSMC6 in LUAD, we observed that the proteasome subunits, such as PSMD10, PSMD6, PSMD9, PSMD13, PSMB3, PSMB1, PSMA4, PSMC1, PSMC2, PSMD7, and PSMD14, were highly correlated with PSMC6 expression.
    [Show full text]